Democrats block Trump’s $2.8B weapons transfer to Israel

Rep. Gregory Meeks, the top Democrat on the House Foreign Affairs Committee, announced a hold on a proposed $2.8 billion arms sale to Israel on September 16, blocking a package that includes 40,000 heavy 2,000-pound bombs.

Meeks cited concerns about compliance with US and international law, particularly regarding civilian safety in densely populated areas like Gaza and Lebanon.

What’s in the package

The $2.8 billion sale breaks down into three categories of ordnance: 20,000 MK-84 general-purpose bombs, 20,000 BLU-117 bombs, and 20,000 I-2000 penetrator warheads. All of them fall into the 2,000-pound class, which is the heaviest conventional bomb category regularly used by Western militaries.

The Biden administration previously paused transfers of this same class of bomb over similar concerns about civilian harm. The Trump administration reversed course after taking office, and the pipeline has been open since.

A hold with an expiration date

The most likely path forward is an emergency determination by Secretary of State Marco Rubio. This mechanism allows the administration to bypass the standard congressional review period by declaring that the sale serves urgent national security interests. It’s a move that previous administrations, including Trump’s first term, have used in similar situations involving Israel and Gulf states.

Meeks’s statement reaffirmed his commitment to Israel’s security while emphasizing the importance of congressional oversight.

The broader pattern

Since taking office, the Trump administration has facilitated over $12 billion in arms sales to Israel. That includes a $6.67 billion package approved in January 2026.

In April 2026, Sen. Bernie Sanders led an effort to block a smaller arms package. The Senate voted it down, but between 36 and 40 Democratic senators backed the resolutions.

The acceleration in arms transfers traces back to the October 2023 Hamas attacks and the subsequent Israeli military operations.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.